B. J. Maron, J. A. Towbin, G. Thiene, C. Antzelevitch, D. Corrado et al., Contemporary Definitions and Classification of the Cardiomyopathies An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention, vol.113, pp.1807-1823, 2006.

A. G. Japp, A. Gulati, S. A. Cook, M. R. Cowie, and S. K. Prasad, The Diagnosis and Evaluation of Dilated Cardiomyopathy, J Am Coll Cardiol. 28 juin, vol.67, issue.25, pp.2996-3010, 2016.

G. W. Dec and V. Fuster, Idiopathic Dilated Cardiomyopathy, N Engl J Med. 8 déc, vol.331, issue.23, pp.1564-75, 1994.

S. Rakar, G. Sinagra, A. D. Lenarda, A. Poletti, R. Bussani et al., Epidemiology of dilated cardiomyopathy, Eur Heart J. 1 janv, vol.18, issue.1, pp.117-140, 1997.

L. Tavazzi, Epidemiology of dilated cardiomyopathy: a still undetermined entity, Eur Heart J. 1 janv, vol.18, issue.1, pp.4-6, 1997.

M. Galinier, O. Lairez, J. Roncalli, N. Dumonteil, P. Maury et al., Cardiomyopathies dilatées primitives et secondaires. EMC-Cardiol, janv, vol.6, issue.1, pp.1-12, 2011.

, Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies, Br Heart J. déc, vol.44, issue.6, pp.672-675, 1980.

, Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies, Circulation. 3 janv, vol.93, issue.5, pp.841-843, 1996.

J. P. Kaski and P. Elliott, The classification concept of the ESC Working Group on myocardial and pericardial diseases for dilated cardiomyopathy, Herz Kardiovaskuläre Erkrank, vol.32, issue.6, pp.446-451, 2007.

P. Elliott, B. Andersson, E. Arbustini, Z. Bilinska, F. Cecchi et al., Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases, Eur Heart J. 1 janv, vol.29, issue.2, pp.270-276, 2008.

J. Haas, K. S. Frese, B. Peil, W. Kloos, A. Keller et al., Atlas of the clinical genetics of human dilated cardiomyopathy, Eur Heart J. 7 mai, vol.36, issue.18, pp.1123-1158, 2015.

R. E. Hershberger, A. Morales, and J. D. Siegfried, Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals, Genet Med Off J Am Coll Med Genet, vol.12, issue.11, pp.655-67, 2010.

D. S. Herman, L. Lam, M. Taylor, L. Wang, P. Teekakirikul et al., Truncations of Titin Causing Dilated Cardiomyopathy, N Engl J Med. 16 févr, vol.366, issue.7, pp.619-647, 2012.

X. Li, R. Luo, H. Gu, Y. Deng, X. Xu et al., Cardiac troponin T (TNNT2) mutations in chinese dilated cardiomyopathy patients, BioMed Res Int, p.907360, 2014.

L. Verga, M. Concardi, A. Pilotto, O. Bellini, M. Pasotti et al., Loss of lamin A/C expression revealed by immuno-electron microscopy in dilated cardiomyopathy with atrioventricular block caused by LMNA gene defects, Virchows Arch. 26 juill, vol.443, issue.5, pp.664-71, 2003.

A. Pérez-serra, R. Toro, O. Campuzano, G. Sarquella-brugada, P. Berne et al., A novel mutation in lamin a/c causing familial dilated cardiomyopathy associated with sudden cardiac death, J Card Fail. mars, vol.21, issue.3, pp.217-242, 2015.

T. M. Olson, V. V. Michels, S. N. Thibodeau, Y. S. Tai, and M. T. Keating, Actin mutations in dilated cardiomyopathy, a heritable form of heart failure, Science. 1 mai, vol.280, issue.5364, pp.750-752, 1998.

X. Guo, Y. Dai, L. Cui, and Q. Fang, A novel dystrophin deletion mutation in a becker muscular dystrophy patient with early-onset dilated cardiomyopathy, Can J Cardiol. août, vol.30, issue.8, pp.956-957, 2014.

E. E. Norgett, S. J. Hatsell, L. Carvajal-huerta, J. Cabezas, J. Common et al., Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma, Hum Mol Genet. 11 janv, vol.9, issue.18, pp.2761-2767, 2000.

J. L. Jefferies and J. A. Towbin, Dilated cardiomyopathy. The Lancet. 5 mars, vol.375, pp.752-62, 2010.

J. Duan, G. E. Mcfadden, A. J. Borgerding, F. L. Norby, B. H. Ren et al., Overexpression of alcohol dehydrogenase exacerbates ethanol-induced contractile defect in cardiac myocytes, Am J Physiol-Heart Circ Physiol. 1 avr, vol.282, issue.4, pp.1216-1238, 2002.

M. R. Piano, Alcoholic cardiomyopathy*: Incidence, clinical characteristics, and pathophysiology, Chest. 1 mai, vol.121, issue.5, pp.1638-50, 2002.

J. Fernández-sola, J. M. Nicolas, J. Oriola, E. Sacanella, R. Estruch et al., Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy, Ann Intern Med, vol.137, issue.5_Part_1, pp.321-326, 2002.

X. Pivot, T. Suter, J. M. Nabholtz, J. Y. Pierga, M. Espie et al., Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III study, Eur J Cancer. sept, vol.51, issue.13, pp.1660-1666, 2015.

W. Maharsy, A. Aries, O. Mansour, H. Komati, and M. Nemer, Ageing is a risk factor in imatinib mesylate cardiotoxicity, Eur J Heart Fail. janv, vol.16, issue.4, pp.367-76, 2014.

, Insuffisance cardiaque chronique. Cardiomyopathies GIBELIN Pierre Collection "Les Précis"-Edition Lavoisier Médecine Science

H. Mahrholdt, A. Wagner, C. C. Deluigi, E. Kispert, S. Hager et al., Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis, Circulation, vol.114, issue.15, pp.1581-90, 2006.

E. B. Lieberman, G. M. Hutchins, A. Herskowitz, N. R. Rose, and K. L. Baughman, Clinicopathologic description of myocarditis, J Am Coll Cardiol. déc, vol.18, issue.7, pp.1617-1643, 1991.

R. A. Kyle, M. A. Gertz, P. R. Greipp, T. E. Witzig, J. A. Lust et al., A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, N Engl J Med. 24 avr, vol.336, issue.17, pp.1202-1209, 1997.

D. Hilfiker-kleiner, K. Sliwa, and H. Drexler, Peripartum Cardiomyopathy: Recent Insights in its Pathophysiology, Trends Cardiovasc Med. juill, vol.18, issue.5, pp.173-182, 2008.

J. S. Ware, J. Li, E. Mazaika, C. M. Yasso, T. Desouza et al., Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies, N Engl J Med. 21 janv, vol.374, issue.3, pp.233-274, 2016.

S. Park, S. W. Park, G. Casaclang-verzosa, S. R. Ommen, P. A. Pellikka et al., Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: Data from the Acorn trial, Am Heart J. 1 avr, vol.157, issue.4, p.762, 2009.

E. P. Tsagalou, M. Anastasiou-nana, E. Agapitos, A. Gika, S. G. Drakos et al., Depressed Coronary Flow Reserve Is Associated With Decreased Myocardial Capillary Density in Patients With Heart Failure Due to Idiopathic Dilated Cardiomyopathy, J Am Coll Cardiol, vol.52, issue.17, pp.1391-1399, 2008.

B. Brembilla-perrot, A. F. Suty-selton, C. Huttin, O. Blangy, H. Sadoul et al., Nonischemic Dilated Cardiomyopathy: Results of Noninvasive and Invasive Evaluation in 310 Patients and Clinical Significance of Bundle Branch Block, Pacing Clin Electrophysiol, vol.31, issue.11, pp.1383-90, 2008.

D. Andreini, G. Pontone, M. Pepi, G. Ballerini, A. L. Bartorelli et al., Diagnostic Accuracy of Multidetector Computed Tomography Coronary Angiography in Patients With Dilated Cardiomyopathy, J Am Coll Cardiol. 22 mai, vol.49, issue.20, pp.2044-50, 2007.

D. Andreini, G. Pontone, A. L. Bartorelli, P. Agostoni, S. Mushtaq et al., SixtyFour-Slice Multidetector Computed Tomography An Accurate Imaging Modality for the Evaluation of Coronary Arteries in Dilated Cardiomyopathy of Unknown Etiology, Circ Cardiovasc Imaging. 5 janv, vol.2, issue.3, pp.199-205, 2009.

M. Machii, H. Satoh, K. Shiraki, M. Saotome, T. Urushida et al., Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: Differential diagnosis and prediction of cardiac outcome, Magn Reson Imaging. 1 févr, vol.32, issue.2, pp.118-142, 2014.

X. Li, C. Chan, W. Hua, L. Ding, J. Wang et al., Prognostic impact of late gadolinium enhancement by cardiac magnetic resonance imaging in patients with nonischaemic dilated cardiomyopathy, Int J Cardiol, vol.168, issue.5, pp.4979-80, 2013.

S. Parnham, J. B. Selvanayagam, E. Haan, W. Heddle, D. Pasquale et al., Lamin A/C mutation: An easily missed opportunity, Int J Cardiol. 15 févr, vol.181, p.44, 2015.

P. F. Binkley, A. Lesinski, J. P. Ferguson, P. S. Hatton, L. Yamokoski et al., Recovery of normal ventricular function in patients with dilated cardiomyopathy: Predictors of an increasingly prevalent clinical event, Am Heart J. janv, vol.155, issue.1, pp.69-74, 2008.

K. K. Ho, K. M. Anderson, W. B. Kannel, W. Grossman, and D. Levy, Survival after the onset of congestive heart failure in Framingham Heart Study subjects, Circulation. 1 juill, vol.88, issue.1, pp.107-122, 1993.

C. G. Frazier, K. P. Alexander, L. K. Newby, S. Anderson, E. Iverson et al., Associations of Gender and Etiology With Outcomes in Heart Failure With Systolic Dysfunction: A Pooled Analysis of 5 Randomized Control Trials, J Am Coll Cardiol. 3 avr, vol.49, issue.13, pp.1450-1458, 2007.

V. Vaccarino, E. Gahbauer, S. V. Kasl, P. A. Charpentier, D. Acampora et al., Differences between African Americans and whites in the outcome of heart failure: Evidence for a greater functional decline in African Americans, Am Heart J. juin, vol.143, issue.6, pp.1058-67, 2002.

M. Grogan and A. Dispenzieri, Natural history and therapy of AL cardiac amyloidosis, Heart Fail Rev. 2 déc, vol.20, issue.2, pp.155-62, 2014.

D. L. Dries, D. V. Exner, M. J. Domanski, B. Greenberg, and L. W. Stevenson, The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction, J Am Coll Cardiol. 1 mars, vol.35, issue.3, pp.681-690, 2000.

N. G. Mahon, E. H. Blackstone, G. S. Francis, I. Starling, . Rc et al., The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure, J Am Coll Cardiol, vol.40, issue.6, pp.1106-1119, 2002.

D. L. Dries, N. K. Sweitzer, M. H. Drazner, L. W. Stevenson, and B. J. Gersh, Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction, J Am Coll Cardiol. août, vol.38, issue.2, pp.421-429, 2001.

J. Adams, M. Kuchibhatla, E. J. Christopher, J. D. Alexander, G. L. Clary et al., Association of Depression and Survival in Patients with Chronic Heart Failure over 12 Years, Psychosomatics, vol.53, issue.4, pp.339-385, 2012.

J. Muntwyler, One-year mortality among unselected outpatients with heart failure, Eur Heart J. 1 déc, vol.23, issue.23, pp.1861-1867, 2002.

B. A. Bart, L. K. Shaw, M. Cb, D. F. Fortin, K. L. Lee et al., Clinical Determinants of Mortality in Patients With Angiographically Diagnosed Ischemic or Nonischemic Cardiomyopathy, J Am Coll Cardiol, vol.30, issue.4, pp.1002-1010, 1997.

T. B. Horwich, G. C. Fonarow, M. A. Hamilton, W. R. Maclellan, M. A. Woo et al., The relationship between obesity and mortality in patients with heart failure, J Am Coll Cardiol. sept, vol.38, issue.3, pp.789-95, 2001.

P. P. Gupta, G. C. Fonarow, and T. B. Horwich, Obesity and the Obesity Paradox in Heart Failure, Can J Cardiol. févr, vol.31, issue.2, pp.195-202, 2015.

K. Swedberg, M. Komajda, M. Böhm, J. S. Borer, I. Ford et al., Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. The Lancet. 17 sept, vol.376, pp.875-85, 2010.

H. V. Huikuri and P. K. Stein, Heart Rate Variability in Risk Stratification of Cardiac Patients, Prog Cardiovasc Dis. sept, vol.56, issue.2, pp.153-162, 2013.

H. C. Doval, D. R. Nul, H. O. Grancelli, S. D. Varini, S. Soifer et al., Nonsustained Ventricular Tachycardia in Severe Heart Failure, Circulation. 15 déc, vol.94, issue.12, pp.3198-203, 1996.

S. He and L. Wang, The Impact of Anemia on the Prognosis of Chronic Heart Failure: A Meta-Analysis and Systemic Review, Congest Heart Fail. 1 mai, vol.15, issue.3, pp.123-153, 2009.

P. Van-der-meer, A. A. Voors, E. Lipsic, T. Smilde, W. H. Van-gilst et al., Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure, J Am Coll Cardiol. 7 juill, vol.44, issue.1, pp.63-70, 2004.

J. Myers, L. Gullestad, R. Vagelos, D. Do, D. Bellin et al., Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited, Am Heart J. janv, vol.139, issue.1, pp.78-84, 2000.

H. Philipson, I. Ekman, H. B. Forslund, K. Swedberg, and M. Schaufelberger, Salt and fluid restriction is effective in patients with chronic heart failure, Eur J Heart Fail, vol.15, issue.11, pp.1304-1314, 2013.

G. Aliti, E. R. Rabelo, N. Clausell, L. E. Rohde, A. Biolo et al., Aggressive fluid and sodium restriction in acute decompensated heart failure: A randomized clinical trial, JAMA Intern Med. 24 juin, vol.173, issue.12, pp.1058-64, 2013.

*. Group and . Tcts, Effects of Enalapril on Mortality in Severe Congestive Heart Failure, N Engl J Med. 4 juin, vol.316, issue.23, pp.1429-1464, 1987.

*. Investigators and . Ts, Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure, N Engl J Med. 1 août, vol.325, issue.5, pp.293-302, 1991.

M. Rivero-ayerza, D. Theuns, H. M. Garcia-garcia, E. Boersma, M. Simoons et al., Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials, Eur Heart J, vol.27, issue.22, pp.2682-2690, 2006.

M. R. Bristow, L. A. Saxon, J. Boehmer, S. Krueger, D. A. Kass et al., CardiacResynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure, N Engl J Med. 20 mai, vol.350, issue.21, pp.2140-50, 2004.

J. Cleland, J. Daubert, E. Erdmann, N. Freemantle, D. Gras et al., The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure, N Engl J Med. 14 avr, vol.352, issue.15, pp.1539-1588, 2005.

C. Linde, W. T. Abraham, M. R. Gold, . J. St, M. Sutton et al., Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms, J Am Coll Cardiol. 2 déc, vol.52, issue.23, pp.1834-1877, 2008.

A. Tang, G. A. Wells, M. Talajic, M. O. Arnold, R. Sheldon et al., CardiacResynchronization Therapy for Mild-to-Moderate Heart Failure, N Engl J Med. 16 déc, vol.363, issue.25, pp.2385-95, 2010.

P. Ponikowski, A. A. Voors, S. D. Anker, H. Bueno, J. Cleland et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur Heart J. 14 juill, vol.37, issue.27, pp.2129-200, 2016.

M. Gasparini, A. Auricchio, F. Regoli, C. Fantoni, M. Kawabata et al., FourYear Efficacy of Cardiac Resynchronization Therapy on Exercise Tolerance and Disease Progression: The Importance of Performing Atrioventricular Junction Ablation in Patients With Atrial Fibrillation, J Am Coll Cardiol. 15 août, vol.48, issue.4, pp.734-777, 2006.

M. Gasparini, A. Auricchio, M. Metra, F. Regoli, C. Fantoni et al., Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation, Eur Heart J. juill, vol.29, issue.13, pp.1644-52, 2008.

A. B. Curtis, P. B. Adamson, C. E. , J. Sutton, M. S. Tang et al., Biventricular Versus Right Ventricular Pacing in Patients with AV Block (BLOCK HF): Clinical Study Design and Rationale, J Cardiovasc Electrophysiol. 1 sept, vol.18, issue.9, pp.965-71, 2007.

W. Mullens, R. A. Grimm, T. Verga, T. Dresing, R. C. Starling et al., Insights From a Cardiac Resynchronization Optimization Clinic as Part of a Heart Failure Disease Management Program, J Am Coll Cardiol. 3 mars, vol.53, issue.9, pp.765-73, 2009.

S. G. Priori, C. Blomström-lundqvist, A. Mazzanti, N. Blom, M. Borggrefe et al., ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, Eur Heart J, vol.36, issue.41, pp.2793-867, 2015.

D. Bänsch, M. Antz, S. Boczor, M. Volkmer, J. Tebbenjohanns et al., Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT), Circulation. 26 mars, vol.105, issue.12, pp.1453-1461, 2002.

A. Kadish, A. Dyer, J. P. Daubert, R. Quigg, N. Estes et al., Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy, N Engl J Med. 20 mai, vol.350, issue.21, pp.2151-2159, 2004.

G. H. Bardy, K. L. Lee, D. B. Mark, J. E. Poole, D. L. Packer et al., Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure, N Engl J Med. 20 janv, vol.352, issue.3, pp.225-262, 2005.

A. F. Members, K. Dickstein, A. Cohen-solal, G. Filippatos, J. Mcmurray et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008, Eur Heart J, vol.29, pp.2388-442, 2008.

S. F. Bolling, F. D. Pagani, G. M. Deeb, and D. S. Bach, Intermediate-Term Outcome Of Mitral Reconstruction In Cardiomyopathy, J Thorac Cardiovasc Surg. 1 févr, vol.115, issue.2, pp.381-389, 1998.

M. J. Mack, New techniques for percutaneous repair of the mitral valve, Heart Fail Rev, vol.11, issue.3, pp.259-68

D. Cles, Agence de la biomédecine, 2015.

F. M. Sarullo, G. Fazio, I. Brusca, S. Fasullo, S. Paterna et al., Exercise Testing in Patients with Chronic Heart Failure: Prognostic Comparison from Peak VO2 and VE/VCO2 Slope, Open Cardiovasc Med J. 26 mai, vol.4, pp.127-161, 2010.

L. C. Davies, R. Wensel, P. Georgiadou, M. Cicoira, A. Coats et al., Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by nonlinear analysis: oxygen uptake efficiency slope, Eur Heart J. 1 mars, vol.27, issue.6, pp.684-90, 2006.

P. Ponikowski, A. A. Voors, S. D. Anker, H. Bueno, J. Cleland et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur Heart J. 14 juill, vol.37, issue.27, pp.2129-200, 2016.

C. M. Tracy, A. E. Epstein, D. Darbar, J. P. Dimarco, S. B. Dunbar et al., , 2012.

A. Update and . The, Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, vol.60, issue.14, pp.1297-313, 2008.

A. F. Members, K. Dickstein, A. Cohen-solal, G. Filippatos, J. Mcmurray et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008, Eur Heart J, vol.29, pp.2388-442, 2008.

M. Rivero-ayerza, D. Theuns, H. M. Garcia-garcia, E. Boersma, M. Simoons et al., Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials, Eur Heart J, vol.27, issue.22, pp.2682-2690, 2006.

E. Marijon, L. Trinquart, A. Otmani, X. Waintraub, S. Kacet et al., Competing risk analysis of cause-specific mortality in patients with an implantable cardioverterdefibrillator: The EVADEF cohort study, Am Heart J. févr, vol.157, issue.2, pp.391-397, 2009.

S. M. Al-khatib, A. Hellkamp, G. H. Bardy, S. Hammill, J. Hall et al., Survival of Patients Receiving a Primary Prevention Implantable CardioverterDefibrillator in Clinical Practice vs Clinical Trials, JAMA J Am Med Assoc. 2 janv, vol.309, issue.1, pp.55-62, 2013.

B. D. Powell, L. A. Saxon, J. P. Boehmer, J. D. Day, I. Gilliam et al., Survival After Shock Therapy in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy-Defibrillator Recipients According to Rhythm Shocked: The ALTITUDE Survival by Rhythm Study, J Am Coll Cardiol, vol.62, issue.18, pp.1674-1683, 2013.

P. L. Hess, A. S. Hellkamp, E. D. Peterson, G. D. Sanders, A. Hr et al., Survival After Primary Prevention Implantable Cardioverter-Defibrillator Placement Among Patients With Chronic Kidney Disease, Circ Arrhythm Electrophysiol. 10 janv, vol.7, issue.5, pp.793-802, 2014.

L. Fauchier, E. Marijon, P. Defaye, O. Piot, N. Sadoul et al., Effect of Age on Survival and Causes of Death After Primary Prevention Implantable CardioverterDefibrillator Implantation, Am J Cardiol. 15 mai, vol.115, issue.10, pp.1415-1437, 2015.

D. S. Lee, J. Hardy, R. Yee, J. S. Healey, D. Birnie et al., Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators, Circ Heart Fail. 9 janv, vol.8, issue.5, pp.927-964, 2015.

J. E. Poole, G. W. Johnson, A. S. Hellkamp, J. Anderson, D. J. Callans et al., Prognostic importance of defibrillator shocks in patients with heart failure, N Engl J Med, vol.359, issue.10, pp.1009-1026, 2008.

R. Proietti, C. Labos, M. Davis, G. Thanassoulis, P. Santangeli et al., A Systematic Review and Meta-analysis of the Association Between Implantable CardioverterDefibrillator Shocks and Long-term Mortality, Can J Cardiol. 1 mars, vol.31, issue.3, pp.270-277, 2015.

P. Weeke, J. B. Johansen, O. D. Jørgensen, J. C. Nielsen, M. Møller et al., Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register, Europace. 1 août, vol.15, issue.8, pp.1150-1157, 2013.

L. Guédon-moreau, C. Kouakam, D. Klug, C. Marquié, F. Brigadeau et al., Decreased Delivery of Inappropriate Shocks Achieved by Remote Monitoring of ICD: A Substudy of the ECOST Trial, J Cardiovasc Electrophysiol. 1 juill, vol.25, issue.7, pp.763-70, 2014.

J. H. Yang, K. Byeon, H. R. Yim, J. W. Park, S. Park et al., Predictors and Clinical Impact of Inappropriate Implantable Cardioverter-Defibrillator Shocks in Korean Patients, J Korean Med Sci. juin, vol.27, issue.6, pp.619-643, 2012.

A. J. Moss, C. Schuger, C. A. Beck, M. W. Brown, D. S. Cannom et al., Reduction in Inappropriate Therapy and Mortality through ICD Programming, N Engl J Med. 13 déc, vol.367, issue.24, pp.2275-83, 2012.

L. Guédon-moreau, C. P. Marquié, C. Kouakam, C. Klug, D. Lacroix et al., Contributions of remote monitoring to the follow-up of implantable cardioverterdefibrillator leads under advisory, Eur Heart J. sept, vol.31, issue.18, pp.2246-52, 2010.

A. D. Simone, L. Leoni, M. Luzi, C. Amellone, G. Stabile et al., Remote monitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study, Europace. 1 août, vol.17, issue.8, pp.1267-75, 2015.

N. Varma, J. Michalski, B. Stambler, and B. B. Pavri, Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trialtesting execution of the recommendations, Eur Heart J. 21 mai, vol.35, issue.20, pp.1345-52, 2014.

C. Witt, G. Wu, D. Yang, D. Hodge, V. Roger et al., Outcomes With Left Bundle Branch Block and Mildly to Moderately Reduced Left Ventricular Function.pdf, JACC Heart Fail, 2016.

L. A. Saxon, M. R. Bristow, J. Boehmer, S. Krueger, D. A. Kass et al., Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION), Trial. Circulation. 19 déc, vol.114, issue.25, pp.2766-72, 2006.

M. O. Sweeney, M. S. Wathen, K. Volosin, I. Abdalla, P. J. Degroot et al., Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients Results From the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II), Trial. Circulation. 6 juill, vol.111, issue.22, pp.2898-905, 2005.

N. Clementy, B. Pierre, B. Lallemand, O. Marie, E. Lemoine et al., Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction, Europace. 1 juill, vol.14, issue.7, pp.968-74, 2012.

R. Providência, S. Boveda, N. Combes, H. Hireche, S. Combes et al., The benefit of implantable cardioverter defibrillator programming in MADIT-RIT: more for less?, Europace. 1 sept, vol.15, issue.9, pp.1229-1259, 2013.

L. Køber, J. J. Thune, J. C. Nielsen, J. Haarbo, L. Videbaek et al., Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure, N Engl J Med

D. Bänsch, M. Antz, S. Boczor, M. Volkmer, J. Tebbenjohanns et al., Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT), Circulation. 26 mars, vol.105, issue.12, pp.1453-1461, 2002.

S. A. Strickberger, J. D. Hummel, T. G. Bartlett, H. I. Frumin, C. D. Schuger et al., Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia-AMIOVIRT, J Am Coll Cardiol. 21 mai, vol.41, issue.10, pp.1707-1719, 2003.

A. Kadish, A. Dyer, J. P. Daubert, R. Quigg, N. Estes et al., Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy, N Engl J Med. 20 mai, vol.350, issue.21, pp.2151-2159, 2004.

G. H. Bardy, K. L. Lee, D. B. Mark, J. E. Poole, D. L. Packer et al., Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure, N Engl J Med. 20 janv, vol.352, issue.3, pp.225-262, 2005.

M. R. Bristow, L. A. Saxon, J. Boehmer, S. Krueger, D. A. Kass et al., CardiacResynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure, N Engl J Med. 20 mai, vol.350, issue.21, pp.2140-50, 2004.

S. G. Priori, C. Blomström-lundqvist, A. Mazzanti, N. Blom, M. Borggrefe et al., ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, Eur Heart J, vol.36, issue.41, pp.2793-867, 2015.

A. S. Desai, J. C. Fang, W. H. Maisel, and K. L. Baughman, Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: A meta-analysis of randomized controlled trials, JAMA. 15 déc, vol.292, issue.23, pp.2874-2883, 2004.

Z. Wang, M. Liu, T. Pan, and S. Tong, Lower Mortality Associated With Overweight in the U.S. National Health Interview Survey, Medicine, vol.15, issue.2016

Y. Sakr, I. Alhussami, R. Nanchal, R. G. Wunderink, T. Pellis et al., Being Overweight Is Associated With Greater Survival in ICU Patients: Results From the Intensive Care Over Nations Audit, Crit Care Med. déc, vol.43, issue.12, pp.2623-2655, 2015.

H. Takagi and T. Umemoto, Overweight, but not obesity, paradox on mortality following coronary artery bypass grafting, J Cardiol. 1 sept, vol.68, issue.3, pp.215-236, 2016.

P. P. Gupta, G. C. Fonarow, and T. B. Horwich, Obesity and the Obesity Paradox in Heart Failure, Can J Cardiol. févr, vol.31, issue.2, pp.195-202, 2015.

B. Bozkurt and A. Deswal, Obesity as a prognostic factor in chronic symptomatic heart failure, Am Heart J. 1 déc, vol.150, issue.6, pp.1233-1242, 2005.

M. Cicoira, A. P. Maggioni, R. Latini, S. Barlera, E. Carretta et al., Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial, Eur J Heart Fail. 1 avr, vol.9, issue.4, pp.397-402, 2007.

T. B. Horwich, G. C. Fonarow, M. A. Hamilton, W. R. Maclellan, M. A. Woo et al., The relationship between obesity and mortality in patients with heart failure, J Am Coll Cardiol. sept, vol.38, issue.3, pp.789-95, 2001.

D. L. Dries, D. V. Exner, M. J. Domanski, B. Greenberg, and L. W. Stevenson, The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction, J Am Coll Cardiol. 1 mars, vol.35, issue.3, pp.681-690, 2000.

N. G. Mahon, E. H. Blackstone, G. S. Francis, I. Starling, . Rc et al., The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure, J Am Coll Cardiol, vol.40, issue.6, pp.1106-1119, 2002.

A. C. Alba, J. Braga, M. Gewarges, S. D. Walter, G. H. Guyatt et al., Predictors of Mortality in Patients With an Implantable Cardiac Defibrillator: A Systematic Review and Metaanalysis, Can J Cardiol. 1 déc, vol.29, issue.12, pp.1729-1769, 2013.

A. J. Moss, H. Greenberg, R. B. Case, W. Zareba, W. J. Hall et al., Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator, Circulation. 21 déc, vol.110, issue.25, pp.3760-3765, 2004.

A. Pacifico, L. L. Ferlic, F. R. Cedillo-salazar, N. Nasir, T. K. Doyle et al., Shocks as predictors of survival in patients with implantable cardioverter-defibrillators, J Am Coll Cardiol. juill, vol.34, issue.1, pp.204-214, 1999.

M. D. Smit, P. Dessel, M. Rienstra, W. Nieuwland, A. Wiesfeld et al., Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients, Europace. 1 août, vol.8, issue.8, pp.566-72, 2006.

L. Iles, H. Pfluger, L. Lefkovits, M. J. Butler, P. M. Kistler et al., Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable CardioverterDefibrillators for Primary Prevention of Sudden Cardiac Death, J Am Coll Cardiol. 15 févr, vol.57, issue.7, pp.821-829, 2011.

C. Et-perspectives,

A. J. Moss, C. Schuger, C. A. Beck, M. W. Brown, D. S. Cannom et al., Reduction in Inappropriate Therapy and Mortality through ICD Programming, N Engl J Med. 13 déc, vol.367, issue.24, pp.2275-83, 2012.

N. Clementy, B. Pierre, B. Lallemand, O. Marie, E. Lemoine et al., Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction, Europace. 1 juill, vol.14, issue.7, pp.968-74, 2012.

G. H. Bardy, W. M. Smith, M. A. Hood, I. G. Crozier, I. C. Melton et al., An Entirely Subcutaneous Implantable Cardioverter-Defibrillator, N Engl J Med. 1 juill, vol.363, issue.1, pp.36-44, 2010.

S. Aziz, A. R. Leon, and M. F. El-chami, The Subcutaneous Defibrillator: A Review of the Literature, J Am Coll Cardiol. 22 avr, vol.63, issue.15, pp.1473-1482, 2014.

S. G. Priori, C. Blomström-lundqvist, A. Mazzanti, N. Blom, M. Borggrefe et al., ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, Eur Heart J, vol.36, issue.41, pp.2793-867, 2015.

L. Køber, J. J. Thune, J. C. Nielsen, J. Haarbo, L. Videbaek et al., Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure, N Engl J Med